Podchaser Logo
Home
Antibody-Drug Conjugates: Transforming Breast Cancer Treatment

Antibody-Drug Conjugates: Transforming Breast Cancer Treatment

Released Wednesday, 24th May 2023
Good episode? Give it some love!
Antibody-Drug Conjugates: Transforming Breast Cancer Treatment

Antibody-Drug Conjugates: Transforming Breast Cancer Treatment

Antibody-Drug Conjugates: Transforming Breast Cancer Treatment

Antibody-Drug Conjugates: Transforming Breast Cancer Treatment

Wednesday, 24th May 2023
Good episode? Give it some love!
Rate Episode

The Private Cancer Physician’s Podcast series on Managing Patients with Cancer is pleased to release its new podcast: Antibody-Drug Conjugates: Transforming Breast Cancer TreatmentIn this podcast, we discuss antibody-drug conjugates (ADCs) and the transformative role they are playing in the fight against metastatic breast cancer. ADCs are “smart bombs” that provide a new construct to treat metastatic breast cancer, with higher efficacy and less off target toxicities. Dr Richard de Boer, Medical Oncologist from the Peter MacCallum Cancer Centre is joined by Professor Hope Rugo, Director, Breast Oncology and Clinical Trials Education and Medical Director of Cancer Infusion Services, UCSF as well as Dr Belinda Yeo, Medical Oncologist from the Austin Hospital in Melbourne, Australia, and Clinician Scientist from the Olivia Newton-John Cancer Research Institute.Produced by ScienceToLife

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features